ÂÜÀòÂÒÂ×

Dr. Brennan is the founder, president, and former CEO of Gene Logic (NASDAQ: GLGC). His experience as a successful entrepreneur for a biotech company that uses information as a key part of its business model translates especially well to Cloud Pharmaceuticals. During Dr. Brennan’s time at Gene Logic, he built the company from a start-up to a public company that achieved a market capitalization of over $5 billion. Dr. Brennan was previously a general partner at Oxford Bioscience Partners. He also served as vice president, business development for Boehringer Mannheim Therapeutics.